πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) β€” grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≀24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months β€” use filters for patent-cliff planning.

Page 14 of 21

  1. US 8039623

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8039475

    Co-crystals and pharmaceutical compositions comprising the same

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8034832

    Gyrase inhibitors and uses thereof

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8034950

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8022041

    Prodrug of an ICE inhibitor

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8022202

    Dihydrodiazepines useful as inhibitors of protein kinases

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8017781

    Azaindazoles useful as inhibitors of kinases

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8017619

    Compositions useful as inhibitors of protein kinases

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8012999

    Modulators of CFTR

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8003685

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8003660

    Modulators of muscarinic receptors

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7999113

    Modulators of cystic fibrosis transmembrane conductance regulator

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7998987

    Inhibitors of c-Met and uses thereof

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7994174

    Pyridyl sulfonamides as modulators of ion channels

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7994166

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7989481

    Indane derivatives as modulators of ion channels

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7989456

    Pyrazine kinase inhibitors

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7989498

    Inhibitors of IMPDH enzyme

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7985769

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7985762

    Inhibitors of serine proteases

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7982037

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7977322

    Modulators of ATP-binding cassette transporters

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7973162

    Modulators of muscarinic receptors

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7973169

    Modulators of ATP-Binding Cassette transporters

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7972813

    Tetrodotoxin-resistant sodium channel alpha subunit

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7973038

    Modulators of ATP-binding cassette transporters

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7968716

    Caspase inhibitors and uses thereof

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7964624

    Inhibitors of serine proteases

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7960415

    Caspase inhibitors and uses thereof

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7960398

    Regulation of TNF-alpha

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7956052

    Modulators of ATP-binding cassette transporters

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7951809

    Inhibitors of p38

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7943593

    Compositions comprising inhibitors of IMPDH enzyme

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7928107

    Quinazolines useful as modulators of ion channels

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7919513

    Inhibitors of p38

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7919523

    Inhibitors of aspartyl protease

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7919520

    Inhibitors of tace

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7915385

    Sodium channel protein type III Ξ±-subunit splice variant

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7915305

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7906650

    Caspase inhibitors and uses thereof

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7906550

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7902239

    Diaminotriazoles useful as inhibitors of protein kinases

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7888384

    Heterocyclic derivatives for modulation of calcium channels

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7883881

    Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7884199

    HCV NS3-NS4 protease resistance mutants

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7880007

    Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.